Injected matrix stimulates myogenesis and regeneration of mouse skeletal muscle after ischaemic injury

European Cells and Materials

Volumn 24, Issue , 2012, Pages 175-196

  Kuraitis, D ^a,b,c   Ebadi, D ^b   Zhang, P ^a   Rizzuto, E ^c   Vulesevic, B ^a,b   Padavan, D T ^a   Al Madhoun, A ^b   McEwan, K A ^a,b   Sofrenovic, T ^a,b   Nicholson, K ^a   Whitman, S C ^a   Mesana, T G ^a   Skerjanc, I S ^b   Musaro A ^c   Ruel, M ^a,b   Suuronen, E J ^a,b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Hydrogel; Injectable; Muscle; Neovascularisation; Regenerative medicine; Tissue material interactions

Indexed keywords

BIOMATERIAL; CADHERIN; M CADHERIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 3; MYOGENIC FACTOR 5; MYOGENIN; SIALYL LEWIS X ANTIGEN COLLAGEN MATRIX; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR SIX1; UNCLASSIFIED DRUG; 5 ACETYLNEURAMINYL (2 3) GALACTOSYL (1 4) (FUCOPYRANOSYL (1 3)) N ACETYLGLUCOSAMINE; 5-ACETYLNEURAMINYL-(2-3)-GALACTOSYL-(1-4)-(FUCOPYRANOSYL-(1-3))-N-ACETYLGLUCOSAMINE; COLLAGEN; HOMEODOMAIN PROTEIN; INSULIN LIKE GROWTH FACTOR 1, MOUSE; INSULIN-LIKE GROWTH FACTOR-1, MOUSE; M-CADHERIN; MYF5 PROTEIN, MOUSE; MYOG PROTEIN, MOUSE; OLIGOSACCHARIDE; PAIRED BOX TRANSCRIPTION FACTOR; PAX3 PROTEIN, MOUSE; SIX1 PROTEIN, MOUSE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL REGENERATION; CONTROLLED STUDY; ELASTICITY; EMBRYO; EMBRYONIC STEM CELL; ENGRAFTMENT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MOUSE; MUSCLE DEVELOPMENT; MUSCLE FATIGUE; MUSCLE INJURY; MUSCLE ISCHEMIA; MUSCLE REGENERATION; NONHUMAN; PROTEIN SYNTHESIS; REGENERATIVE MEDICINE; ANIMAL; C57BL MOUSE; CELL LINE; CHEMISTRY; CYTOLOGY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETICS; ISCHEMIA; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; PATHOLOGY; PHYSIOLOGY; REGENERATION; SKELETAL MUSCLE; TRANSPLANTATION; VASCULARIZATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CADHERINS; CELL LINE; COLLAGEN; EMBRYONIC STEM CELLS; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HOMEODOMAIN PROTEINS; INSULIN-LIKE GROWTH FACTOR I; ISCHEMIA; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED C57BL; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOGENIC REGULATORY FACTOR 5; MYOGENIN; OLIGOSACCHARIDES; PAIRED BOX TRANSCRIPTION FACTORS; REGENERATION;

EID: 84872041453     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v024a13     Document Type: Article

References (72)

1. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B (2007) Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167: 989-997.
2. Bayol S, Loughna PT, Brownson C (2000) Phenotypic expression of IGF binding protein transcripts in muscle, in vitro and in vivo. Biochem Biophys Res Commun 273: 282-286.
3. Bernal A, San Martin N, Fernandez M, Covarello D, Molla F, Soldo A, Latini R, Cossu G, Galvez BG (2011) L-selectin and SDF-1 enhance the migration of mouse and human cardiac mesoangioblasts. Cell Death Differ 19: 345-355.
4. Biancone L, Cantaluppi V, Duo D, Deregibus MC, Torre C, Camussi G (2004) Role of L-selectin in the vascular homing of peripheral blood-derived endothelial progenitor cells. J Immunol 173: 5268-5274.
5. Boodhwani M, Voisine P, Ruel M, Sodha NR, Feng J, Xu SH, Bianchi C, Sellke FW (2008) Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction. Eur J Cardiothorac Surg 33: 645-650.
6. Borselli C, Storrie H, Benesch-Lee F, Shvartsman D, Cezar C, Lichtman JW, Vandenburgh HH, Mooney DJ (2010) Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci U S A 107: 3287-3292.
7. Carosio S, Berardinelli MG, Aucello M, Musaro A (2011) Impact of ageing on muscle cell regeneration. Ageing Res Rev 10: 35-42.
8. Chen FM, Zhang M, Wu ZF (2010) Toward delivery of multiple growth factors in tissue engineering. Biomaterials 31: 6279-6308.
9. Corti S, Nizzardo M, Nardini M, Donadoni C, Salani S, Ronchi D, Simone C, Falcone M, Papadimitriou D, Locatelli F, Mezzina N, Gianni F, Bresolin N, Comi GP (2010) Embryonic stem cell-derived neural stem cells improve spinal muscular atrophy phenotype in mice. Brain 133: 465-481.
10. Deasy BM, Feduska JM, Payne TR, Li Y, Ambrosio F, Huard J (2009) Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle. Mol Ther 17: 1788-1798.
11. Del Prete Z, Musaro A, Rizzuto E (2008) Measuring mechanical properties, including isotonic fatigue, of fast and slow MLC/mIgf-1 transgenic skeletal muscle. Ann Biomed Eng 36: 1281-1290.
12. Deng C, Zhang P, Vulesevic B, Kuraitis D, Li F, Yang AF, Griffith M, Ruel M, Suuronen EJ (2010) A collagen-chitosan hydrogel for endothelial differentiation and angiogenesis. Tissue Eng Part A 16: 3099-3109.
13. Derkaoui SM, Labbe A, Purnama A, Gueguen V, Barbaud C, Avramoglou T, Letourneur D (2010) Films of dextran-graft-polybutylmethacrylate to enhance endothelialization of materials. Acta Biomater 6: 3506-3513.
14. Donalies M, Cramer M, Ringwald M, Starzinski-Powitz A (1991) Expression of M-cadherin, a member of the cadherin multigene family, correlates with differentiation of skeletal muscle cells. Proc Natl Acad Sci U S A 88: 8024-8028.
15. Duan C, Ren H, Gao S (2010) Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation. Gen Comp Endocrinol 167: 344-351.
16. Elliott JT, Woodward JT, Umarji A, Mei Y, Tona A (2007) The effect of surface chemistry on the formation of thin films of native fibrillar collagen. Biomaterials 28: 576-585.
17. Engler AJ, Griffin MA, Sen S, Bonnemann CG, Sweeney HL, Discher DE (2004) Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments. J Cell Biol 166: 877-887.
18. Engler AJ, Sen S, Sweeney HL, Discher DE (2006) Matrix elasticity directs stem cell lineage specification. Cell 126: 677-689.
19. Esposito A, Germinario E, Zanin M, Palade PT, Betto R, Danieli-Betto D (2007) Isoform switching in myofibrillar and excitation-contraction coupling proteins contributes to diminished contractile function in regenerating rat soleus muscle. J Appl Physiol 102: 1640-1648.
20. Ewton DZ, Coolican SA, Mohan S, Chernausek SD, Florini JR (1998) Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5. J Cell Physiol 177: 47-57.
21. Ferreira JC, Bacurau AV, Evangelista FS, Coelho MA, Oliveira EM, Casarini DE, Krieger JE, Brum PC (2008) The role of local and systemic renin angiotensin system activation in a genetic model of sympathetic hyperactivity-induced heart failure in mice. Am J Physiol Regul Integr Comp Physiol 294: R26-32.
22. Frangogiannis NG, Mendoza LH, Lindsey ML, Ballantyne CM, Michael LH, Smith CW, Entman ML (2000) IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J Immunol 165: 2798-2808.
23. Gayraud-Morel B, Chretien F, Flamant P, Gomes D, Zammit PS, Tajbakhsh S (2007) A role for the myogenic determination gene Myf5 in adult regenerative myogenesis. Dev Biol 312: 13-28.
24. Grounds MD (2008) Complexity of extracellular matrix and skeletal muscle regeneration. In: Skeletal Muscle Repair and Regeneration (Schiaffino S, Patridge T, eds), Springer, New York, pp 269-301.
25. Guan K, Rohwedel J, Wobus AM (1999) Embryonic stem cell differentiation models: cardiogenesis, myogenesis, neurogenesis, epithelial and vascular smooth muscle cell differentiation in vitro. Cytotechnology 30: 211-226.
26. Hayward R, Nossuli TO, Scalia R, Lefer AM (1997) Cardioprotective effect of interleukin-10 in murine myocardial ischemia-reperfusion. Eur J Pharmacol 334: 157-163.
27. Kennedy KA, Porter T, Mehta V, Ryan SD, Price F, Peshdary V, Karamboulas C, Savage J, Drysdale TA, Li SC, Bennett SA, Skerjanc IS (2009) Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-catenin. BMC Biol 7: 67.
28. Kimura Y, Tabata Y (2010) Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis. J Biomater Sci 21: 37-51.
29. Klein D, Hohn HP, Kleff V, Tilki D, Ergun S (2010) Vascular wall-resident stem cells. Histol Histopathol 25: 681-689.
30. Ko HC, Milthorpe BK, McFarland CD (2007) Engineering thick tissues-the vascularisation problem. Eur Cell Mater 14: 1-18; discussion 18-19.
31. Koffler J, Kaufman-Francis K, Yulia S, Dana E, Daria AP, Landesberg A, Levenberg S (2011) Improved vascular organization enhances functional integration of engineered skeletal muscle grafts. Proc Natl Acad Sci U S A 108: 14789-14794.
32. Koike T, Vernon RB, Gooden MD, Sadoun E, Reed MJ (2003) Inhibited angiogenesis in aging: a role for TIMP-2. J Gerontol A Biol Sci Med Sci 58: B798-805.
33. Kovanen V (2002) Intramuscular extracellular matrix: complex environment of muscle cells. Exerc Sport Sci Rev 30: 20-25.
34. Kroehne V, Heschel I, Schugner F, Lasrich D, Bartsch JW, Jockusch H (2008) Use of a novel collagen matrix with oriented pore structure for muscle cell differentiation in cell culture and in grafts. J Cell Mol Med 12: 1640-1648.
35. Kuang S, Kuroda K, Le Grand F, Rudnicki MA (2007) Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell 129: 999-1010.
36. Kuraitis D, Giordano C, Ruel M, Musarò A, Suuronen EJ (2012) Exploiting extracellular matrix-stem cell interactions: A review of natural materials for therapeutic muscle regeneration. Biomaterials 33: 428-443.
37. Kuraitis D, Hou C, Zhang Y, Vulesevic B, Sofrenovic T, McKee D, Sharif Z, Ruel M, Suuronen EJ (2011a) Ex vivo generation of a highly potent population of circulating angiogenic cells using a collagen matrix. J Mol Cell Cardiol 51: 187-197.
38. Kuraitis D, Zhang P, Zhang Y, Padavan DT, McEwan K, Sofrenovic T, McKee D, Zhang J, Griffith M, Cao X, Musaro A, Ruel M, Suuronen EJ (2011b) A stromal cell-derived factor-1 releasing matrix enhances the progenitor cell response and blood vessel growth in ischaemic skeletal muscle. Eur Cell Mater 22: 109-123.
39. Li Z, Liu HY, Lei QF, Zhang C, Li SN (2011) Improved motor function in dko mice by intravenous transplantation of bone marrow-derived mesenchymal stromal cells. Cytotherapy 13: 69-77.
40. Limbourg A, Korff T, Napp LC, Schaper W, Drexler H, Limbourg FP (2009) Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia. Nat Protoc 4: 1737-1746.
41. Liu Y, Chu A, Chakroun I, Islam U, Blais A (2010) Cooperation between myogenic regulatory factors and SIX family transcription factors is important for myoblast differentiation. Nucleic Acids Res 38: 6857-6871.
42. Martin TA, Watkins G, Lane J, Jiang WG (2005) Assessing microvessels and angiogenesis in human breast cancer, using VE-cadherin. Histopathology 46: 422-430.
43. McGeachie JK, Grounds MD (1987) Initiation and duration of muscle precursor replication after mild and severe injury to skeletal muscle of mice. An autoradiographic study. Cell Tissue Res 248: 125-130.
44. Millon LE, Oates CJ, Wan W (2009) Compression properties of polyvinyl alcohol-bacterial cellulose nanocomposite. J Biomed Mater Res B Appl Biomater 90: 922-929.
45. Montarras D, Morgan J, Collins C, Relaix F, Zaffran S, Cumano A, Partridge T, Buckingham M (2005) Direct isolation of satellite cells for skeletal muscle regeneration. Science 309: 2064-2067.
46. Musaro A, Rosenthal N (1999) Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I. Mol Cell Biol 19: 3115-3124.
47. Nabeshima Y, Hanaoka K, Hayasaka M, Esumi E, Li S, Nonaka I (1993) Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364: 532-535.
48. Ning Y, Schuller AG, Bradshaw S, Rotwein P, Ludwig T, Frystyk J, Pintar JE (2006) Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3,-4, and-5. Mol Endocrinol 20: 2173-2186.
49. Parise G, O'Reilly CE, Rudnicki MA (2006) Molecular regulation of myogenic progenitor populations. Appl Physiol Nutr Metab 31: 773-781.
50. Pelosi L, Giacinti C, Nardis C, Borsellino G, Rizzuto E, Nicoletti C, Wannenes F, Battistini L, Rosenthal N, Molinaro M, Musaro A (2007) Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines. FASEB J 21: 1393-1402.
51. Ridgeway AG, Skerjanc IS (2001) Pax3 is essential for skeletal myogenesis and the expression of Six1 and Eya2. J Biol Chem 276: 19033-19039.
52. Rossi CA, Pozzobon M, De Coppi P (2010) Advances in musculoskeletal tissue engineering: moving towards therapy. Organogenesis 6: 167-172.
53. Roy S, Khanna S, Kuhn DE, Rink C, Williams WT, Zweier JL, Sen CK (2006) Transcriptome analysis of the ischemia-reperfused remodeling myocardium: temporal changes in inflammation and extracellular matrix. Physiol Genomics 25: 364-374.
54. Rudnicki MA, Schnegelsberg PN, Stead RH, Braun T, Arnold HH, Jaenisch R (1993) MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75: 1351-1359.
55. Ruvinov E, Leor J, Cohen S (2011) The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials 32: 565-578.
56. Sabourin LA, Rudnicki MA (2000) The molecular regulation of myogenesis. Clin Genet 57: 16-25.
57. Saif J, Schwarz TM, Chau DY, Henstock J, Sami P, Leicht SF, Hermann PC, Alcala S, Mulero F, Shakesheff KM, Heeschen C, Aicher A (2010) Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization. Arterioscler Thromb Vasc Biol 30: 1897-1904.
58. San Antonio JD, Iozzo RV (2006)The two-phase model for angiogenesis regulation by the extracellular matrix. In: Encyclopedia of the Microvasculature (D. Shepro, ed), Elsevier Academic Press, Burlington, pp 127-136.
59. Savage J, Conley AJ, Blais A, Skerjanc IS (2009) SOX15 and SOX7 differentially regulate the myogenic program in P19 cells. Stem Cells 27: 1231-1243.
60. Seale P, Ishibashi J, Scime A, Rudnicki MA (2004) Pax7 is necessary and sufficient for the myogenic specification of CD45+:Sca1+ stem cells from injured muscle. PLoS Biol 2: E130.
61. Seeger FH, Rasper T, Koyanagi M, Fox H, Zeiher AM, Dimmeler S (2009) CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia. Arterioscler Thromb Vasc Biol 29: 1802-1809.
62. Shi M, Ishikawa M, Kamei N, Nakasa T, Adachi N, Deie M, Asahara T, Ochi M (2009) Acceleration of skeletal muscle regeneration in a rat skeletal muscle injury model by local injection of human peripheral blood-derived CD133-positive cells. Stem Cells 27: 949-960.
63. Sun D, Martinez CO, Ochoa O, Ruiz-Willhite L, Bonilla JR, Centonze VE, Waite LL, Michalek JE, McManus LM, Shireman PK (2009) Bone marrow-derived cell regulation of skeletal muscle regeneration. FASEB J 23: 382-395.
64. Suuronen EJ, Kuraitis D, Ruel M (2008) Improving cell engraftment with tissue engineering. Semin Thorac Cardiovasc Surg 20: 110-114.
65. Suuronen EJ, Zhang P, Kuraitis D, Cao X, Melhuish A, McKee D, Li F, Mesana TG, Veinot JP, Ruel M (2009) An acellular matrix-bound ligand enhances the mobilization, recruitment and therapeutic effects of circulating progenitor cells in a hindlimb ischemia model. FASEB J 23: 1447-1458.
66. Vignaud A, Hourde C, Medja F, Agbulut O, Butler-Browne G, Ferry A (2010) Impaired skeletal muscle repair after ischemia-reperfusion injury in mice. J Biomed Biotechnol 2010: 724914.
67. Villalta SA, Rinaldi C, Deng B, Liu G, Fedor B, Tidball JG (2011) Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum Mol Genet 20: 790-805.
68. Wang JS, Liu X, Xue ZY, Alderman L, Tilan JU, Adenika R, Epstein SE, Burnett MS (2011) Effects of aging on time course of neovascularization-related gene expression following acute hindlimb ischemia in mice. Chin Med J (Engl) 124: 1075-1081.
69. Whitman SC, Rateri DL, Szilvassy SJ, Yokoyama W, Daugherty A (2004) Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice. Arterioscler Thromb Vasc Biol 24: 1049-1054.
70. Birch HL (2007) Tendon matrix composition and turnover in relation to functional requirements. Int J Exp Pathol 88: 241-248.
71. Di Santo S, Yang Z, Wyler von Ballmoos M, Voelzmann J, Diehm N, Baumgartner I, Kalka C (2009) Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation. PloS One 4: e5643.
72. Kjaer M (2004) Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev 84: 649-698.